These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Downregulation of exosomal miR-192-5p and miR-204-5p in subjects with nonclassic apparent mineralocorticoid excess. Tapia-Castillo A; Guanzon D; Palma C; Lai A; Barros E; Allende F; Vecchiola A; Fardella CE; Salomón C; Carvajal CA J Transl Med; 2019 Nov; 17(1):392. PubMed ID: 31775784 [TBL] [Abstract][Full Text] [Related]
4. Apparent mineralocorticoid excess syndrome: report of one family with three affected children. Al-Harbi T; Al-Shaikh A J Pediatr Endocrinol Metab; 2012; 25(11-12):1083-8. PubMed ID: 23329753 [TBL] [Abstract][Full Text] [Related]
6. Apparent mineralocorticoid excess: type I and type II. Mantero F; Palermo M; Petrelli MD; Tedde R; Stewart PM; Shackleton CH Steroids; 1996 Apr; 61(4):193-6. PubMed ID: 8732999 [TBL] [Abstract][Full Text] [Related]
7. Apparent mineralocorticoid excess and the long term treatment of genetic hypertension. Razzaghy-Azar M; Yau M; Khattab A; New MI J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):145-150. PubMed ID: 26892095 [TBL] [Abstract][Full Text] [Related]
8. New findings in apparent mineralocorticoid excess. DiMartino-Nardi J; Stoner E; Martin K; Balfe JW; Jose PA; New MI Clin Endocrinol (Oxf); 1987 Jul; 27(1):49-62. PubMed ID: 2820623 [TBL] [Abstract][Full Text] [Related]
9. [From gene to disease; 'apparent mineralocorticoid excess' syndrome, a syndrome with an apparent excess of mineral corticoids]. Levtchenko EN; Deinum J; Knoers NV; Hermus AR; Monnens LA; Lenders JW Ned Tijdschr Geneeskd; 2007 Mar; 151(12):692-4. PubMed ID: 17447595 [TBL] [Abstract][Full Text] [Related]
11. A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension. Odermatt A; Dick B; Arnold P; Zaehner T; Plueschke V; Deregibus MN; Repetto H; Frey BM; Frey FJ; Ferrari P J Clin Endocrinol Metab; 2001 Mar; 86(3):1247-52. PubMed ID: 11238516 [TBL] [Abstract][Full Text] [Related]
12. The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension. Ferrari P; Lovati E; Frey FJ J Hypertens; 2000 Mar; 18(3):241-8. PubMed ID: 10726708 [TBL] [Abstract][Full Text] [Related]
13. Molecular basis for hypertension in the "type II variant" of apparent mineralocorticoid excess. Li A; Tedde R; Krozowski ZS; Pala A; Li KX; Shackleton CH; Mantero F; Palermo M; Stewart PM Am J Hum Genet; 1998 Aug; 63(2):370-9. PubMed ID: 9683587 [TBL] [Abstract][Full Text] [Related]
14. Apparent mineralocorticoid excess type II. Mantero F; Tedde R; Opocher G; Dessi Fulgheri P; Arnaldi G; Ulick S Steroids; 1994 Feb; 59(2):80-3. PubMed ID: 8191552 [TBL] [Abstract][Full Text] [Related]
15. A genetic defect resulting in mild low-renin hypertension. Wilson RC; Dave-Sharma S; Wei JQ; Obeyesekere VR; Li K; Ferrari P; Krozowski ZS; Shackleton CH; Bradlow L; Wiens T; New MI Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10200-5. PubMed ID: 9707624 [TBL] [Abstract][Full Text] [Related]
16. Serum Cortisol and Cortisone as Potential Biomarkers of Partial 11β-Hydroxysteroid Dehydrogenase Type 2 Deficiency. Carvajal CA; Tapia-Castillo A; Valdivia CP; Allende F; Solari S; Lagos CF; Campino C; Martínez-Aguayo A; Vecchiola A; Pinochet C; Godoy C; Iturrieta V; Baudrand R; Fardella CE Am J Hypertens; 2018 Jul; 31(8):910-918. PubMed ID: 29617893 [TBL] [Abstract][Full Text] [Related]
17. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome? Palermo M; Delitala G; Sorba G; Cossu M; Satta R; Tedde R; Pala A; Shackleton CH J Endocrinol Invest; 2000; 23(7):457-62. PubMed ID: 11005270 [TBL] [Abstract][Full Text] [Related]
18. Evidence for cortisol as the mineralocorticoid in the syndrome of apparent mineralocorticoid excess. Tedde R; Pala A; Melis A; Ulick S J Endocrinol Invest; 1992 Jun; 15(6):471-4. PubMed ID: 1401749 [TBL] [Abstract][Full Text] [Related]
19. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess. Whorwood CB; Stewart PM J Hypertens Suppl; 1996 Dec; 14(5):S19-24. PubMed ID: 9120678 [TBL] [Abstract][Full Text] [Related]
20. Clinical, biochemical, and miRNA profile of subjects with positive screening of primary aldosteronism and nonclassic apparent mineralocorticoid excess. Tapia-Castillo A; Carvajal CA; Pérez JA; Fardella CE Endocrine; 2022 Aug; 77(2):380-391. PubMed ID: 35676467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]